Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you can reduce your Wegovy dose, and in some situations your prescriber may actively recommend it. Dose reduction is a recognised part of managing semaglutide treatment: if side effects are making everyday life difficult, staying on a lower strength until things settle is clinically sensible rather than a step backwards. These are prescription-only medicines, so any change to your dose must be guided by the clinician overseeing your care, not made unilaterally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy's standard titration moves through 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and up to 2.4 mg (or the newer 7.2 mg maintenance dose), with roughly four weeks at each level. That pacing exists because semaglutide's gastrointestinal effects (nausea, vomiting, diarrhoea, reflux, belching) are real and common, and the gradual increase gives your digestive system time to adjust.
Most people find that GI symptoms are worst in the first week or two after a dose increase, then fade. If yours haven't faded after two to three weeks, or if you're struggling to keep food and fluids down, that's a clear signal worth flagging to your prescriber. You'll find a plain-English overview of what each step involves on the Wegovy dosing schedule page.
Don't wait until you're exhausted and miserable. A quick message to your care team while symptoms are still manageable gives you more options than suffering in silence until you want to stop treatment altogether. The side effects at the 1.0 mg dose are well documented; what's less well known is that stepping back down to the previous dose often resolves them within days, and our guide to reducing your Wegovy dose explains exactly how that process works in practice.
This step isn't optional. Wegovy is a prescription-only medicine under the Human Medicines Regulations 2012, and adjusting your dose without clinical input carries real risks, both of undertreating and of inadvertently creating a gap in your schedule that affects how the medicine works.
Your prescriber needs to know: how severe the symptoms are, how long they've lasted, whether you've had any dehydration, and whether anything else has changed (new medicines, illness, surgery planned). That full picture shapes their recommendation. They might suggest a temporary reduction, a longer hold at the current dose, or in some cases an extended period at a lower strength if your progress and tolerability both point that way.
At nume, a GPhC-registered prescriber reads every message the same day (a real clinician, not automated software) so you're not waiting days for an answer when you need one. If you're already a patient, priority aftercare is available seven days a week.
Dropping back a dose level doesn't reset your progress. Weight loss slows at lower doses, but it doesn't reverse simply because you're on 1.0 mg rather than 1.7 mg for an extra month. Clinical trials for semaglutide, including the STEP 1 study published in the New England Journal of Medicine, built their titration schedules specifically to allow tolerability time, the final result figures reflect a programme that included exactly these kinds of adjustments for some participants.
What matters is staying on treatment consistently. A small saving of time on the dose ladder is worth nothing if side effects drive you to stop. The weight-loss treatment overview covers how Wegovy fits into a broader plan alongside diet and activity changes, which don't pause just because your dose has temporarily stepped back.
If you're curious about whether going in the other direction is an option, there's a separate guide on increasing your Wegovy dose ahead of the standard schedule. The short answer there is the same: it's a clinical decision, not a self-service one.
A dose reduction is not the same as discontinuing treatment, and the two should be treated very differently. Reducing to a more tolerable level keeps the medicine working and keeps your prescriber engaged with your progress. Stopping entirely (especially abruptly) can lead to weight returning, sometimes quickly, and should be a considered decision rather than a response to one bad week.
NHS guidance on weight-management injections emphasises that these medicines work best alongside sustained lifestyle support, and that clinical supervision throughout is important. If you've been wondering whether a lower dose long-term might suit you better than pushing to the maximum, that's a reasonable question, our prescribers hear it most weeks. The answer depends on your individual response, your weight trajectory, and any other health factors in play.
For a broader picture of the medicine itself, the Wegovy overview covers licensing, how it works, and what to expect from treatment. And if you'd like a prescriber to review your current situation properly, you can check your eligibility for a free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.